
I blew £500k on cocaine, gambling & food and weighed 19st – but surprising side effect of fat jabs cured my addictions
RUMMAGING through her packed wardrobe Vivienne Joy struggles to find something that still fits.
Since starting Mounjaro three and a half months ago she has so far lost almost 2st and dropped two dress sizes - going from size 24 to 20 - which means she desperately needs new clothes, but she has no urge to buy a single item.
7
7
It's hard to believe that for the last five years she has been in the grip of a full-blown shopping addiction splurging £500 a month on impulsive purchases.
And Vivienne's addictive tendencies didn't end there - across 22 years, from the age of 18, she blew a six-figure sum on gambling and takeaways, as well as clothes and cocaine combined, and at one point she was in £250,000 worth of debt.
Vivienne, 53, replaced one addiction with another, yet within days of starting fat jabs in February, the need to spend recklessly to feel a 'high' totally stopped.
Now, she dares to hope that her addictive personality is finally 'cured' thanks to the jabs which adjust the levels of dopamine - the pleasure chemical - in the brain.
Vivienne estimates she's even saved £1,500 a month since she started the injections.
She says: 'For 34 years I moved from one addiction to another because I was always looking for that high, but I feel calm and in control since starting Mounjaro.
'I started gambling when I was 18 and must have got through around £500,000 in the 22 years that I was hooked – on several occasions I spent £1,000 a night on slot machines.
'I earned a lot, six figures at times, but I spent a lot and ended up with £250,000 of debt.
'And I was addicted to food throughout too, gorging on whole cakes, boxes of doughnuts and Sausage and Egg McMuffins from McDonalds.
'I used to party hard, taking cocaine regularly between the ages of 28 to 35 and although it wasn't daily, I couldn't find the off switch.
Weight Loss Jabs - Pros vs Cons
'My life was filled with compulsions. But now, finally, those cravings have stopped.'
The number of weight loss jab NHS prescriptions has surged in the UK, doubling to almost three million in the past year.
Demand for Ozempic (semaglutide) and Mounjaro (tirzepatide) - Vivienne sourced the latter through a private clinic spending £179 a month because of obesity, high BMI and felt out of control around food - shows no signs of slowing, with the total bill costing the NHS £269million in 2024/2025.
It follows The Sun's recent survey which revealed how 73 per cent of readers are considering using jabs to lose weight.
Scientists are already exploring the link between the injections and addiction.
Dr Daniel Gordon, from Olive Health, who prescribes the jabs privately to patients at his clinic in London, says: 'Scientists think the drugs work by blunting our reward responses.
'Weight-loss jabs like Ozempic and Mounjaro seem to quieten the brain's 'pleasure circuits' that drive cravings and addictions.
'For example, in scientific studies, people with alcohol use disorder who took low-dose semaglutide drank significantly fewer units of alcohol per day and felt less of an urge to smoke.
'The early signs suggest these jabs could become a game-changer for tackling addictive behaviour as well as obesity.'
'Game-changer'
Vivienne, who lives in Retford, Notts, with wife Emma, 43, a dog behaviourist, turned to weight loss jabs after a stint on Slimming World in May 2024.
She was a size 26 (having dropped to a size 24 by the time she started Mounjaro) and weighed 19st 10lbs but had battled with her weight her whole life.
'We'd been on an all-inclusive holiday to Greece and over indulged and decided we had to get a grip on our weight,' Vivienne recalls.
'Although I lost 1st 7lbs in nine months, it was torturous.
'I was fighting every step of the way not to indulge in my junk foods, like McDonalds and doughnuts.
'Emma started at 14st 2lbs and lost the same amount but she wasn't having to battle temptation.
'All her lapses were down to me constantly suggesting takeaways, eating out and junk food – I unwittingly sabotaged her weight loss.
'She's not an addictive person, she can take or leave most things – I can't.'
Vivienne struggled with her weight from the age of 13 and while food was her most visible addiction, others soon began to develop and at 18 she started gambling.
She explains: 'My parents loved bingo and slot machines and would go three or four times a week. On my 18th birthday I joined them and spent all day and night gambling.
'It didn't seem problematic to start with, I was going socially with them. But then they died within eight months of each other when I was 30 and I started going alone, mindlessly feeding pound coins into the slot machine.
'I've always earned good money so it wasn't a problem financially. I did have debts on credit cards and loans but I was able to service them from my wages'
7
7
It was when I was 37 and working as a regional company director for a beauty company that Vivienne was made redundant and she struggled to find a new job.
Within five months her debts became impossible to service and owing £200,000 in credit cards and loans she had to file an IVA which meant agreeing to pay off a portion of the debts whilst the rest were written off.
'Dark time'
'It was a very low and dark time,' Vivienne recalls.
'But once I found a new job I was so addicted that I went back to gambling. Because of the IVA I couldn't get into debt again because I couldn't physically get credit. But the fact I even gambled shows how strong my addiction was. When I was 40 there was a week when I spent £1,000 a night for three days in a row. I knew then it had to stop and I managed with the help of hypnotherapy.
'But it didn't help with my root problem of always searching for that dopamine hit.'
Vivienne met her ex husband in a nightclub in 2002 when she was 29, and they married four years later.
'At that stage of my life I was partying hard at the weekends,' she admits.
'I'd started taking cocaine a year before. I was always the last one to stop, wanting to keep that dopamine hit going. I quit aged 35, after I stayed up all night taking it on a Wednesday and went into work the next day. No one noticed but I knew and felt ashamed of myself – it wasn't the person I wanted to be."
It was in lockdown that Vivienne turned to online shopping online as well as continuing her food addiction.
It was 2020, seven years after her marriage ended and she was living with Emma when her addiction spiralled.
She explains: 'We couldn't go out for dinner or socialise and as usual I needed that dopamine hit from somewhere so I started online shopping. I didn't do half measures.
'I'd scroll on my phone for hours. There was rarely a day that went past without a delivery arriving.
'I loved getting clothes for Emma too alongside kitchen gadgets, candles, crystals and even toys for our four dogs. Emma would gently suggest it was getting out of hand and I didn't need more clothes, but I ignored her.
'But it was mindless, I bought two of the same jacket without even realising and I've got 20 pairs of similar shoes from Rocket Dog.
'It was the buying that gave me the buzz, often parcels would arrive and I'd have no idea what was in them. But back then I didn't think it was an issue.'
Food has been Vivienne's most constant addiction throughout her life and one she thought she'd never conquer.
She says: 'I'd buy a cake and devour it in a day and if I bought a box of six doughnuts I couldn't stop thinking about them until they were all gone.
'I once went to a Chinese restaurant in my dressing gown as I wanted it so much and immediately.
'Another time I went to three different McDonalds in one morning to get the sausage and egg McMuffin I craved.
I want to think I'm cured – I feel liberated, I can focus on my work completely
Vivienne
'That's why I decided to try the weight loss injections because I didn't feel in control.'
Vivienne says the jabs eliminated the ' food noise ' completely.
She also no longer felt the urge to search for the 'highs' which, until then, had blighted her life.
'I no longer think about food or the need to get that 'high' like I used to in the same way. I feel normal now,' Vivienne says.
'I've lost a further 1st 9lbs in three and half months - 2lbs more than I lost in nine months on Slimming World.
"And Emma has lost another 10lbs. I finally feel that losing weight isn't a battle – I don't really think about food. My goal is to lose eight stone leaving me at 11st 11lbs – that seems doable.'
Vivienne now saves the £500 she spent online shopping, plus £400 on takeaways and junk food and £100 on eating out. And a further £500 on other shopping, such as bulk buying things like deodorant and candles, as well as going out to theatre and then dinner.
'It's saved us a fortune. I want to think I'm cured – I feel liberated, I can focus on my work completely,' she adds.
Warning about using fat jabs to cure addictions, Dr Gordon adds: "People should never use these medications as a self-prescribed treatment for addictions or cravings.
"They are potent prescription-only medications, with complex effects and some significant risks. They are not a replacement for proper psychological or addiction support."
Vivienne, a mindset coach, knows addiction is deep rooted but believes the jabs have set her on the right path.
She feels hopeful for the future.
'I can't rely on Mounjaro for the rest of my life – the root causes of my addiction will still be there,' she adds.
'But what it's giving me is time to recalibrate my brain. I no longer have compulsive thoughts whirling around my head.'
7
7
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
26 minutes ago
- Daily Mail
NHS patients battling Alzheimer's WON'T be offered 'miracle' drugs as health watchdog rules they are 'too expensive to justify'
Two of the first drugs proven to slow down Alzheimer's disease will be denied to NHS patients from this week - unless they pay to go private. The National Institute for Health and Care Excellence (NICE) has refused the 'miracle' drugs lecanemab and donanemab for use on the NHS as they are too expensive to justify. This means over 70,000 patients in England will be denied the 'game-changing' drugs, found to slow cognitive decline by an average of four to seven months, unless they can afford tens of thousands of pounds a year for private treatment. After a positive drug trial in 2022, lecanemab (brand name Leqembi) made by Eisai, and donanemab (marketed as Kisunla), made by Eli Lilly, were proven to clear toxic amyloid protein from the brain and thus slow the underlying cause of dementia. Campaigners hailed it as 'the beginning of the end' of Alzheimer's. Iain Hartnell, Research Communications Officer at Alzheimer's Society, said: 'The MHRA's approval of the first safe and effective Alzheimer's disease treatment, shown to slow progression, is a defining moment for people with early-stage Alzheimer's disease in the UK and a significant step towards a more hopeful future.' Last year, both drugs were given drug licences in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA). But without NICE's recommendation, the groundbreaking medicine will only be available to those with private healthcare. 'It is the end of the road for these drugs on the NHS,' an insider told The Times. Hilary Evans-Newton, the chief executive of Alzheimer's Research UK described the decision as 'deeply disappointing'. She told the publication that it sends 'a damaging signal to the life sciences sector - undermining confidence in the UK as a leader of dementia research, clinical trials and innovation, with knock-on effects for patients and the wider economy'. She added: 'These treatments are not perfect, and we recognise the challenges they pose around cost, delivery and safety. But scientific progress is incremental, and these drugs represent a vital foundation to build on.' The drugs were shown in trials to slow the rate of decline for those with mild to moderate Alzheimer's by an average of four to seven months. Lecanemab, for example, can slow the decline in memory and mental agility by 27 per cent in those with mild Alzheimer's taking the drug compared to people on the dummy drug. The research team also found that the drug reduced loss of quality of life by up to 56 per cent, according to the Alzheimer's Society. Importantly, the drug reduced the amount of amyloid protein present in the brain. Amyloid protein levels were also reduced in the blood and spinal fluid. Experts have long believed donanemab could herald a new era of dementia treatment, after studies showed it slowed the memory-robbing illness in its early stages Lecanemab has already been given the green light in the EU, US, China, Japan, Hong Kong, South Korea and Israel. It is estimated around 70,000 adults in England could eligible for the treatment if approved for use on the health service. Alzheimer's is the most common cause of dementia in the UK. Around 982,000 are currently estimated to be living with dementia UK - although this figure is expected to skyrocket to 1.4million in 2040. Alzheimer's Research UK analysis found 74,261 people died from dementia in 2022, compared to 69,178 a year earlier, making it the country's biggest killer. Recent analysis by the Alzheimer's Society estimates the overall annual cost of the dementia to the UK is £42billion a year, with families bearing the brunt. An ageing population means these costs — which include lost earnings of unpaid carers — are set to soar to £90billion in the next 15 years.


Daily Mail
an hour ago
- Daily Mail
The secrets to beating the 8am scramble for GP appointments by the people who really know - the receptionists! And at least one of them is VERY surprising...
The secrets to beating the 8am scramble for GP appointments by the people who really know - the receptionists! And at least one of them is VERY surprising... They're often painted as the grim-faced gatekeepers of the overstretched NHS. Manning the phone lines to surgeries, GP receptionists have long borne the brunt of patients' growing frustration with the primary care system.


BBC News
an hour ago
- BBC News
Sainsburys and Morrisons told to stop advertising heated tobacco
The government has written to Sainsbury's and Morrisons asking them to stop "advertising and promoting" heated tobacco products, which it says is against the BBC reported in February the supermarkets were displaying posters and video screens showing devices which create a nicotine-containing vapour by heating tobacco with an electric the time, both supermarkets said they believed the adverts were response to the letter, Sainsbury's said it was in "close contact with the government", while Morrisons said it would reply "in due course". In 2002, the Labour government under Tony Blair passed a law banning tobacco advertising. It defined a tobacco product as something designed to be "smoked, sniffed, sucked or chewed".Morrisons has argued that this means that it doesn't apply to heated tobacco products, as they don't produce for Philip Morris International's (PMI) iQos heated tobacco device on posters and video screens was still on display in Sainsbury's and Morrisons stores visited by the BBC in June, where they were visible to said it believes the Department of Health's interpretation of the law is wrong, and said it has "complied with all applicable laws and regulations" since it launched iQos in government has now written to the supermarkets clarifying that in its opinion, the law does apply to these products.A Department of Health and Social Care (DHSC) spokesperson told the BBC: "In May, we wrote to supermarkets reiterating that the Tobacco Advertising and Promotion Act 2002… applies to all tobacco products currently on the market, and formally requested they stop advertising and promoting heated tobacco products in stores."All tobacco products are harmful to health," the spokesperson added. Surveys by the charity Action on Smoking and Health suggest that awareness of heated tobacco products has risen sharply over the past year, and is even higher among young adults, compared with those over 40. Among 11 to 17-year-olds, nearly a quarter had heard of heated tobacco, up from 7.1% in 2022, the last time they were 3.3% of respondents to their survey said they had tried heated tobacco, and for 11 to 17-year-olds, the figure was 2.7%. While low, the charity said this was still "worryingly similar to the levels of use among adults".Experts say that although research on the health effects of heated tobacco is limited, it is likely to be less harmful than cigarettes, but worse for you than vapes, and less effective at helping smokers heated tobacco products a new health risk?A spokesperson for Morrisons said it was reviewing the letter and would respond "in due course".Sainsbury's said it believed its ads were compliant with the law. A spokesperson said: "We remain in close contact with the government and industry partners and are planning our transition to ensure we also comply with planned incoming legislation."It would be for a court to rule definitively whether the government is right that heated tobacco advertising is banned under current law - but so far no-one has brought a law will be clarified when the government passes the Tobacco and Vapes Bill, which is expected to conclusively ban all tobacco and vape advertising and bill is making its way through parliament and is currently at the committee stage in the House of Cheeseman, the chief executive of Action on Smoking and Health, urged the government to pass the law as quickly as possible. "It is outrageous that certain supermarkets still do not seem to be prepared to comply with the law, even when told they are in breach."The longer this takes to resolve, the more children will be exposed to tobacco product marketing," she Tobacco Advertising and Promotion Act applies UK-wide, but health is a devolved issue. The devolved administrations in Northern Ireland, Wales and Scotland all said they agreed with the DHSC in England that advertising heated tobacco is and Tesco both said they do not accept tobacco advertising.